Use of an electronic medication management support system in patients with polypharmacy in general practice: study protocol of a quantitative process evaluation of the AdAM trial.

"Conflict of interest statement: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."

"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Innovation Fund of the German Federal Joint Committee [grant number 01NVF16006]."

"Trial registration and ethics approval: ClinicalTrials.gov, NCT03430336. Registered on February 6, 2018. https://clinicaltrials.gov/ct2/show/NCT03430336 . The AdAM study was approved by the ethics committee of the Association of Physicians in the German North Rhine region (Ärztekammer Nordrhein, 2017184, 26th of July, 2017), that oversees applications from the city of Wuppertal, where the lead manager of the AdAM study (BARMER statutory health insurance) is situated. Informed consent to participate is obtained by all patients or a caregiver on the patient’s behalf in written form."